Stocks
Immunome (IMNM) ROA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -208.5% | -38.5% | -42.2% | -156.0% | -71.9% | -118.9% | ||
| Changes by years, y/y, % | -32pp | +170pp | -4pp | -114pp | +84pp | -16.4% | |||
Immunome. ROA, %
Immunome. ROA, changes, pp
Immunome (IMNM) ROA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROA, % | ? | -24.0% | -71.8% | -72.6% | -88.6% | -118.9% | -118.9% | |
| Changes by years, y/y, % | +97pp | +84pp | -10pp | -25pp | -95pp | |||
| Changes by quarters, q/q, % | +40pp | -48pp | -1pp | -16pp | -30pp | |||
